Skip to main content

Table 2 Methylation levels of four CpG sites in C3 promoter between CAD and controls

From: A preliminary study showing no association between methylation levels of C3 gene promoter and the risk of CAD

CpG site

CAD (%)

Control (%)

P

P a

1

56.1 ± 6.7

54.5 ± 8.3

0.124

0.123

2

57.3 ± 6.8

55.9 ± 8.0

0.195

0.174

3

61.1 ± 6.6

59.8 ± 7.5

0.180

0.175

4

59.6 ± 6.8

58.6 ± 7.8

0.192

0.169

Average

58.5 ± 6.6

57.1 ± 7.8

0.165

0.153

  1. C3 component 3, CAD coronary artery disease, Pa adjustment for EH, DM, and smoking status
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X